Optimising tablet release with hybrid fusion testing
Webinar Overview
Some companies are now adopting at-line or off-line non-destructive testing for tablets, usually using a single spectroscopic method. But what might be possible through combining different non-destructive testing techniques, and how could this influence the analytical testing of Oral Solid Dose products in laboratories?
This webinar was originally hosted by the Community for Analytical Measurement Science (CAMS) as part of FutureLab: Chemistry in the Digital Age Online Webinar Week. To learn more about CAMS, visit CAMS-UK.
Wednesday, October 15th, 2025
11:00 EDT | 16:00 GMT
Speakers
Andrew Anderson
Consultant
Andrew Anderson is a strategic pharma leader with extensive expertise in small molecule development and advanced analytical technologies. At GSK and Johnson & Johnson, he led the technology strategy, roadmaps, automation, and Process Analytical Technology (PAT) across R&D and commercial operations. Recognized for forging impactful government, academic, and cross-pharma partnerships, Andrew promotes innovation through cross-functional leadership and comprehensive tech implementation, delivering measurable improvements in efficiency, data integrity, and resource optimization.